H.C. Wainwright Maintains Buy on ASLAN Pharmaceuticals, Lowers Price Target to $2

H.C. Wainwright maintains ASLAN Pharmaceuticals (NASDAQ:ASLN) with a Buy and lowers the price target from $9 to $2.

Benzinga · 11/14/2019 12:36

H.C. Wainwright maintains ASLAN Pharmaceuticals (NASDAQ:ASLN) with a Buy and lowers the price target from $9 to $2.